2,3-Dichloroquinoxaline - CAS 2213-63-0
Catalog: |
BB017419 |
Product Name: |
2,3-Dichloroquinoxaline |
CAS: |
2213-63-0 |
Synonyms: |
2,3-dichloroquinoxaline |
IUPAC Name: | 2,3-dichloroquinoxaline |
Description: | 2,3-Dichloroquinoxaline (CAS# 2213-63-0) is a dichlorinated quinoxaline derivative with antimicrobial activity. 2,3-Dichloroquinoxaline is used in the preparation of quinoxaline derivatives of cancer chemopreventive activity. |
Molecular Weight: | 199.04 |
Molecular Formula: | C8H4Cl2N2 |
Canonical SMILES: | C1=CC=C2C(=C1)N=C(C(=N2)Cl)Cl |
InChI: | InChI=1S/C8H4Cl2N2/c9-7-8(10)12-6-4-2-1-3-5(6)11-7/h1-4H |
InChI Key: | SPSSDDOTEZKOOV-UHFFFAOYSA-N |
Boiling Point: | 269.7 °C at 760 mmHg |
Melting Point: | 150-155 °C |
Flash Point: | greater than 167 °F |
Purity: | 95 % |
Density: | 1.486 g/cm3 |
Appearance: | Gray solid. |
Storage: | Store in a cool, dry place. Store in a tightly closed container. |
MDL: | MFCD00006720 |
LogP: | 2.93660 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113264978-A | Novel molecular targeting anti-tumor aza steroid derivative based on lipotoxicity, preparation and application thereof | 20210109 |
CN-112028879-A | Electron transport material, organic electroluminescent device and display device | 20200929 |
CN-112341447-A | Electron transport material, organic electroluminescent device and display device | 20200929 |
US-2021299123-A1 | Survivin-targeting anti-tumor agents and uses thereof | 20200306 |
WO-2021141078-A1 | Photoelectric conversion element, imaging element, and optical sensor | 20200110 |
PMID | Publication Date | Title | Journal |
22316553 | 20120301 | AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents | Bioorganic & medicinal chemistry |
21145626 | 20110101 | Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives | European journal of medicinal chemistry |
20149490 | 20100501 | Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents | European journal of medicinal chemistry |
18440096 | 20081001 | Synthesis, structure elucidation and antibacterial evaluation of new steroidal -5-en-7-thiazoloquinoxaline derivatives | European journal of medicinal chemistry |
18455270 | 20080901 | Synthesis, characterization and in vitro antibacterial activity of new steroidal 5-en-3-oxazolo and thiazoloquinoxaline | European journal of medicinal chemistry |
Complexity: | 147 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 197.9751535 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 197.9751535 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS